Apheon Bioscience is molecular biology and recombinant antibody contract research organization that specializes in recombinant DNA development and tumor antigen discovery services. Apheon has a cancer tumor antigen identification system that profiles tumor tissue to find targetable disease antigens and biomarkers. This all-in-one system also provides therapeutic antibody leads for first-in-class immunotherapies. We engage in antibody contract research and develop strategic partnerships with pharmaceutical companies to develop cancer therapies and diagnostic tests using our system. We also provide molecular biology goods and services, such as DNA cloning services, to the life sciences industry.